Overdose deaths in the U.S. fell by nearly 30,000 last year, marking a significant decline in the drug crisis. Experts are cautiously optimistic about the progress, attributing it to improved treatment access and changes in the drug supply.
In a pivotal court ruling, Judge Mark Pittman denied compounding pharmacies' request for an injunction against the FDA's decision on the semaglutide shortage. This ruling keeps strict timelines for exiting the market, leaving many in the industry concerned.
